AZTR Azitra, Inc.
Azitra, Inc. (AZTR) is expected to report earnings on November 11, 2026, after the market close. The consensus earnings estimate is a loss of $0.04 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +5.9% since its last earnings release on August 12, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Azitra, Inc.
Azitra Inc. is an early-stage clinical biopharmaceutical company. It focused on developing innovative therapies for precision dermatology using engineered proteins and topical live biotherapeutic products. Azitra Inc. is based in BRANFORD, Conn.
Sector
Healthcare
Industry
Biotechnology